These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. beta-adrenergic blocking agents. 24. Heterocyclic substituted 1-(aryloxy)-3-[[(amido)alkyl]amino]propan-2-ols. Large MS; Smith LH J Med Chem; 1982 Dec; 25(12):1417-22. PubMed ID: 6130155 [TBL] [Abstract][Full Text] [Related]
4. Further studies regarding the structure activity relationships of beta-adrenoceptor antagonists. Bagwell EE; Williams EM Br J Pharmacol; 1973 Aug; 48(4):686-92. PubMed ID: 4150921 [TBL] [Abstract][Full Text] [Related]
5. Cardioselectivity as a function of molecular structure in beta-adrenoceptor blocking agents of the 1-(para-substituted aryloxy)-3-(isopropylamino)propan-2-ol type. Erez M; Shtacher G; Weinstock M J Med Chem; 1978 Sep; 21(9):982-4. PubMed ID: 31488 [TBL] [Abstract][Full Text] [Related]
6. [Structure-activity relationship of phenoxyalkanolamine derivatives with selective beta 1-receptor blocking action]. Femmer K Pharmazie; 1975 Oct; 30(10):638-42. PubMed ID: 687 [No Abstract] [Full Text] [Related]
10. Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig. Horii D; Kawada T; Takeda K; Imai S Arzneimittelforschung; 1974 Sep; 24(9):1275-7. PubMed ID: 4154764 [No Abstract] [Full Text] [Related]
11. beta-Adrenergic blocking agents. 17. 1-Phenoxy-3-phenoxyalkylamino-2-propanols and 1-alkoxyalkylamino-3-phenoxy-2-propanols. Smith LH; Tucker H J Med Chem; 1977 Dec; 20(12):1653-6. PubMed ID: 22750 [TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic blocking agents. 19. 1-Phenyl-2-[[(substituted-amido)alkyl]amino]ethanols. Large MS; Smith LH J Med Chem; 1980 Feb; 23(2):112-7. PubMed ID: 6102152 [TBL] [Abstract][Full Text] [Related]
14. Cardiac action of carazolol and methypranol in comparison with other beta-receptor blockers. Bartsch W; Dietmann K; Leinert H; Sponer G Arzneimittelforschung; 1977; 27(5):1022-6. PubMed ID: 18157 [TBL] [Abstract][Full Text] [Related]
15. Structure-selectivity relationships of beta-adrenoceptor antagonists in cats. Zakhari S Eur J Pharmacol; 1974 Nov; 29(1):22-9. PubMed ID: 4154860 [No Abstract] [Full Text] [Related]
16. A comparative study of the activity of beta-adrenoceptor antagonists in man. Taylor SH; Thadani U; Davidson C; singleton W; Myint S Int J Clin Pharmacol Biopharm; 1975 Jul; 12(1-2):305-6. PubMed ID: 240783 [TBL] [Abstract][Full Text] [Related]
17. Some adrenergic beta-blocking agents affecting lipolysis in human adipose tissue in vitro. Wenkeová J; Kuhn E; Wenke M Eur J Pharmacol; 1976 May; 37(1):91-5. PubMed ID: 6293 [TBL] [Abstract][Full Text] [Related]
18. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents. Adam KR; Baird JR; Burges RA; Linnell J Eur J Pharmacol; 1974 Feb; 25(2):170-5. PubMed ID: 4154851 [No Abstract] [Full Text] [Related]